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The American College of Obstetrician and Gynecologists have classified the hypertensive
disorders of pregnancy into the following four categories:
1. Pre-eclampsia or pregnancy induced hypertension (PIE) is defined as the triad of hypertension,
proteinuria and generalized oedema, developing after the 20th week of gestation.
2. Chronic hypertension is the presence of sustained hypertension prior to pregnancy and continuing
there into.
3. Superimposed pre-eclampsia implies the development of increased blood pressure, proteinuria,
and/or oedema in a gravida with chronic hypertension.
4. Transient gestational hypertension, refers to development of hypertension without proteinuria or
oederna in a previously normotensive gravida followed by return to normotension within 10 days
postpartum.
Pre-eclampsia remains the most frequent, most serious and least understood of these disorders. The
terminology used to define pre-eclampsia is confusing and atleast eight terntsare used in obstetric
literature today1. Pre-eclampsia is a disease unique to human pregnancy;predominantly affects the
young multiparas. (Frequency is 5 times higher in mothers of less than 20 years, compared to older
than 20 years)2 usually occurs after the 20th week of gestation (may appear earlier in trophoblastic
diseases); the prevalence is 2.5-7% of all the pregnancies in USA and accounts for atleast 20-40%
maternal mortality recorded in U.S.A. and Englan3,4.
Pre-eclampsia is manifested by hypertension, proteinuria and oedema. Oedema is nota reliable
sign1. Pre-eclampsia can be mild, moderate and severe. In severe pre-eclampsia, more than one of
the following must exist:
1. Systolic B.P. >160 torr; DBP >110; MBP >120 ton.
2. Proteinuria in excess of 5 g/24 hours (+3->+4 by dipstick test).
3. Oliguna <500 ml/24 hours.
4. Headache, visual disturbances, cerebral disturbances.
5. Epigastnc pain.
6. HELLP syndrome (haemolysis; elevated liver enzymes; low platelets).
When grandmal convulsions occur in pre-eclampsatic patients, the syndrome is called eclampsia.
1. Pathophysiology
The cause of this multisystemic disorder is yet to be elucidated. Whether the initiating factor of this
disorder is immunological, genetic or simply a decrease in uterine blood flow, is unknown. One
proposed theory is immunological rejection of fetal tissues by the mother which causes placcental
vasculitis and ischaemia. It appears that there are abnormalities in production and effects of circulating
vasoconstricting (angiotensin and thromboxane) and vasodilating (PGE2; prostacyclin and EDRF)
substances, perhaps due to widespread endothelial (immunoreactive) damage5. The abnormal changes
in these hormonal levels produce generalized artenolar vasoreactivity (spasm), retention of salt and
water, and altered coagulation profile (Figure).
II. General management
The management is symptomatic, but the definite therapy is delivery of fetus and placenta. An early
deliveiy has been stressed as crucial in avoiding serious sequelae. The main aim of management should
be directed towards minimizing vasospasm, improving circulation to uterus, placenta and kidneys,
improving the intravascular volume, correcting the acid base and electrolytes imbalance and above all
decreasing reflex hyperactivity and central nervous system activity.
1. Bed rest: Hospitalization and bed rest in lateral decubitus position is strongly advised.
2. Hydration: Adequate hydration and intravascular volume expansion with balanced salt solution is
beneficial6. Sodium intake should be adequate as salt restriction may result in increased production of
renin, angiotensin and aldosterone. The use of thiazide diuretics should be discouraged7.
3. Anti convulsant therapy: Convulsions in these patients could produce deleterious effects on the
mother and fetus. Commonly used anticonvulsant drugs are Benzodiazepines, Phenytoin and
Magnesium Sulphate.
a. Benzodiazepines
Benzodiazepines are the first line of treatment to control convulsions in eclamptic patients. The dose
for Diazepam is 5-10 mg increments until desired effects are obtained. Prophylacitically Intravenous
(fly) infusion of 10 mg/hour of Diazepam can be used. Excessive sedation and airway management
problems for the mother, while flaccidity, hypothermia, severe respiratory depression, low apgar score
are the major disadvantages for the neonate.
b. Phenytoin
Phenytoin is gaining popularity in place of Diazepam due to lack of serious sedative side effects8. The
therapeutic level is 40- 100 micro molll; which could be achieved by a loading dose of 10 mg/kg in 100
ml saline infused intravenously at a rate of 50 mg/mm (7 ml/min in a 70 kg patient), followed by a
second bolus at 5 mg/kg, 2 hours later. Maintenance therapy is commenced 12 hours after the second
bolus, at a rate of 200 mg/S hourly, I.V or orally.
c. Magnesium Sulphate (Mg SO4)
The agent is used for anti-convulsant and uterine vasodilatory effects. It is effective centrally and
peripherally9. Magnesium Sulphate affects the neuromuscular junction by inhibiting the presy naptic
calcium-facilitated transmitter release. The patients receiving MgSO4 are sensitive to Peuromuscular
drugs especially non-depolarizing blockers10. The enhanced effects of Succiny lcholine is due to
deficiency in plasma pseudocholinestase rather than MgSo411. Magnessium sulphate decreases
peripheral resistance, increases cardiacoutput12 atemporaxy decrease in blood pressure which is offset
by an increase in heart rate.
The therapeutic level is 4-6 m Eq/L which can be monitored by deep tendon reflexes and blood levels.
Dose is 40-80 mg/kg followed by an infusion of 2 g/hour. In severe pre-eclampsia for the seizure
prophylaxis magnesium sulphate appears to be a better choice when compared with a drug such as
Phenytoin, as magnesium is an effective vasodilator even of cerebral vessels during cerebral
vasospasm, while Phenytoin acts primarily by suppressing electrical activity13. In another study the
best pennatal outcome was established with diphenylhydantion14.
4. Antihypertensive drugs
Commonly used drugs are Hydralazine, beta-blockers (Propranolol, Atenolol), Ca-Channel blocker
(Vempamil, Nifedipine) Nitrates (Nitroglycerin), Labetalol (alpha and mainly beta blocker with
predominantly beta effects), Sodium Nitroprusside.
a. Hydralazine
The primary actions of Hydralazine is to decrease precapillary arteriolar resistance. It increases cardiac
output and causes reflex tachycardia. The renal blood flow is also increased. Dose is 5 mg bolus
increments till the desired effects are obtained or a maximum dose of 40 mg has been administered. It
is followed by a continuous IN infusion of 5-20 mg/hour(50-350 microgram/min). Maximum effect is
in 20-30 minutes after I.V injection and duration is 2-3 hours. As the onset of action is slow, so
repeated dosage should not be given at less than 20 minutes intervals. If sufficient time is not allowed
between injections severe hypotension may ensure15.
b. Methylodopa
Methylodopa is one of the most commonly used drug in pregnancy induced hypertension. Improved
fetal outcome has been reported in various studiesJt does cross from maternal to umbilical plasnta but
does not cause any ill effects on the fetal heart rate patterns orfetal peripheral resistance. It is used in 1-
3 G/day dosage. Over dosage will cause drowsiness, depression and postural hypotension.
c. Calcium Antagonists
1. Nifedipine 2. Verapamil
1. Nifedipine
Nifedipine is a calcium channel blocker and is effective as a safe antihypertensive agent in pregnancy
particularly in Toxaemia of pregnancy16. Nifedipine causes a decrease in blood pressure. It improves
uterine blood flow and fetal oxygenation17, increases renal blood flow18 and urinary output. Nifedipine
is a potent uterine muscle relaxant so is useful as tocolytic agent, but could calese post-partum
haernorrhage. Dosage is 10mg sublingual Nifediipin every 2 20 minutes till 30 mg is given. Also it can
be used oralty. After oral administration peak effect is in 1-2 hours, witla plasma half life of 5 hours19.
A combination of calcium chan blockers and MgSo4 should be used very cautiously, as hypotension
respiratory difficulty and cardiac toxicity has been reported20.
2. Verapamil
When Verapamil was administered as 5-10 mg/hr via I/V infusion in patients with pregnancy induced
hypertension, after fluid repletion to a pulmonary wedge pressure of 14-16 nun Hg, showed a reduction
in blood pressure in a controlled manner. Both systemic and pulmonary resistance fell but cardiac
output was maintained without any significant side-effects on mother and fetus21.
d. Beta-Blockers
The use of beta-blockers during pregnancy is a controversial issue. The non-selective beta-blocker are
feared to be associated with increased uterine activity, decreased uterine and placental blood flow,
decreased fetal heart rate and decreased fetal tolerance to hypoxia, unacceptable levels of intrauterine
growth retardation and fetal mortality.
Chronic use of cardio-selective beta-blockers, such as Atenolol, appears to be effective to treat
moderate to severe hypertension during pregnancy. A daily dose of 50 mg to a maximum 150 mg/day
when used after 24-3 1 week of pregnancy, resulted in a better control of blood pressure with mild
adverse side effects to mothers and new borns22. In anotherprospective randomized and double blind
study, when Atenolol was used upto a maximum of 200 mg/day, starting from the end of the first
trimester, the drug was associated with significant lower birth weight23.
c. Sodium Nitroprusside and Nitroglycerine
These drugs are to be used only in acute malignant hypertension (hypertensive emergencies). They
might be useful at time of induction and intubation for a rapid control of blood pressure. Esmolol (0.5
mg/kg bolus followed by 0.3 mg/kg/min) or Labetalol 5 mg incremental bolus dosages till 1-2 mg/kg
also have been administered with success mainly at induction and intubation times24.
III. Anaesthetic considerations
One should keep in mind the following points while assessing/managing a patient inlaborwith severe
pre-eclampsia.
1. Cardiovascular systems
There is reduced circulating blood volume with haemoconcentration which will mask the presence of
anaemia. The volume depletion may lead to an exaggeration of the response to aortocaval compression,
therefore, left uterine displacement must be employed. Intravenous fluid loading under the continuous
monitoring of CVP or pulmonary capillary wedge pressure and urine output is necessary before the
conduction of regional or general anaesthesia. There is still controversy about the type of fluids
(crystalloid versus colloid) for preloading and replacement. Volume loading should be done with
caution as these patients have leaking capillaries, decreased oncotic pressures25 and reduced ventricular
compliance. Nisell et al26 examined the effects of acute plasma volume expansion on atrial nathuretic
peplide concentration in 16 pre-eclamptic patients and compared with 16 healthy control patients.
Atrial natriuretic peptide (ANP) has diuretic smooth muscle relaxing and hypotensive properties and is
known to reduce blood volume by increasing capillary permeability. As a result of volume load this
peptide is secreted. There is an enhanced response to ANP in preeclamptic patients, also there is an
increased level in preeclamptic patients. AMP is slowiy cleared owing to poor renal function and
endothelial damage. The increased level of ANP may further exacerbate the capillary leak enhanced
fluid loss and protein into extravascular space. The data strongly suggests against raising the right atrial
pressure to “normal levels”. Woods et al27 found a six-fold increase in incidence of CCF and four-fold
increase of acute respiratory distress syndrome within 24 hours postoperatively in the pre-eclamptic
patients as a result of over enthusiastic fluid loading. Rapid infusion of crystalloid fluid may
significantly lower the colloid oncotic pressure for 24 hours28, which may not be tolerated by these
patients and end up in pulmonary ocdema29. 500-1000 ml of 5% Albumin in severe pre- eclamptics
increases cardiac output, decreases systemic vascular resistance with no or minimal effects on the mean
arterial blood pressure30. The colloidal solution (plasma protein fraction or Albumin 5%) seems to be a
preferable choice in severe preeclamptic patients. Both fluid regimes have their proponents and
opponents. Crystalloid fluids should be without Dextrose. A balanced crystalloid solution or 0.9% Nacl
solution upto a volume load of 500 ml-l000 ml is well tolerated in these patients with epidural
analgesia upto T10 level. A combination of colloid/crystalloid could be a better choice in these patients.
2. Laryngeal oedcma
Retention of sodium and waterand exaggerate effects of normal pregnancy hormones lead to the
development of laryngeal oedema in pre-eclamptic patient. This could cause intubation and post-
operative ainvay management difficulties.
3. Coagulopathy
In the severe pre-eclamptic/eclamptic patients, coagulation disorder might be markedly present. At
admission it is necessary to obtain a complete blood picture with platelets count, followed by serial
platelet counts when monitoring intra-partum coagulation indices. Evaluation of PT, PTT and
flbrinogcn to be added only if platelet count is less than 100.000 per mm331. A rapid change in platelets
count is a more significant event rather than an absolute value32. Platelet functions, rather than number
is more important33, but tests (Thromboelastography) to check the function are time consuming and
expensive. About 10 to 25% of pre-eclamptic patients with normal platelet counts have prolonged
bleeding time33,34.
Schindler et al34 recommended that bleeding times should be performed on all patients with platelet
count between 50,000- 100,000/mm3 prior to invasive regional techniques but some feel that bleeding
time is not a good indicator for coagulation disorders. Fibrin D-Dimer analysis has been proposed as a
more sensitive and early indicator on intravascular coagulation and fibrinolysis than standard coagu
lation tests35. Only if significant coagulation disorderexist with a platelet count falling under 100,000
mm3. a prolonged bleeding time or an abnormal TEG (Thromboelastography) then regional anaesthesia
is relatively contraindicated36
Epidural is absolutely contraindicated when platelets are less than 50,000 mm3. While when platelets
are between 50,000 to 1,00,000 per mm3 risk benefit balance should be assessed as possibility
toepidural haematoma incidence is 1:10,000 cases. There are yet no clear guidelines foracceptable safe
limits but a level of platelets >100,000 mm3 or a bleeding time of<10 minutes is commonly used37. In
the presence of coagulopathy
significant bleeding can occur during laryngoscopy for oral intubation. Attempts should be very gentle
and careful.
4. Drugs interactions
There could be significant effects on the mother’s cardiovascular, muscular, CNS and other systems,
due to the interactions between therapeutic drugs and anaesthetic drugs/techniques.
a. Magnesium sulphate and muscle relaxants
The interactions between magnesium sulphate and muscle relaxants is well documented. The reduction
in the dosage and a continuous monitoring of neuromuscular function with the help of peripheral nerve
stimulator is advisable. b. Magnesium sulphate and regional anaesthesia
The neuromuscular weakness and potential hypotensive effects of magnesium sulphate might be
slightly exaggerated with sympathetic blockade, but the protective and beneficial effects on the uterine
and umbilical blood flow due to epidural anaesthesia eliminates the increased fetal risk21, so
combination is assumed to be safe. Subarachnoid block for higher level is not widely recommended
due to rapid onset of sympathetic block and risk of severe hypotension38,39
c. Use of low dose aspirin and epidurals
The use of low dose aspirin (60 mg/day after the 12th week of pregnancy is based on the rationale that
at this dosage aspirin produced an inhibition of lipid peroxide and thromboxane production but not
prostacyclin production, thus protecting against both vasoconstnction and pathological clotting).
Concerns have been expressed about placing epidurals in patients receiving aspirin as their antiplatelet
actions might increase risk of epidural haematoma. A large multicentral40 randomized placebo control
trial to evaluate the effects of low dose aspirin to prevent and treat pre-eclampsia failed to show any
significant adverse effects on coagulation profile of these patients. There is also no data to recommend
routine bleeding tests on these patients as bleeding time does into indicate the risk of bleeding.
Orlikowsk et al41 noted that chronic use of low dose of Aspirin does not seem to be associated with
TEG (Thromboelastography) changes.
5. Antihypertcnsive drugs and anaesthetic drugs When anaesthetic drugs are administered to the
patients who are on antihypertensive treatment cardiovascular depression may be more pronounced and
marked. The careful choice of anaesthetic drugs and dosage is mandatory. There is a need for titration
of the dose of anaesthetic drugs.
IV. Hyperexaggerated Response
There is increased vascular reactivity which results man intensified response such as tachvcardia,
severe hypertension, due to the release of catecholamines. This particular problem is apparent during
with laryngoscopy, in light general anaesthesia and at extubation. Such sudden rises in blood pressure
may increase the risk of cerebral haemorrhage and oedema, myocardial infarction, pulmonary oedema
or cardiac failure39. Techniques and drugs should be used to obtain or completely abolish these
responses. The general recommendations are to use drugs such as short and rapidly acting anti
hypertensives, xylocaine intravenously or high doses of narcotics, before induction and laryngoscopy.
The stress responses to laryngoscopy could be obtunded by nitroprusside 0.1 to 3 micrograms/kg/min,
just prior to induction42. Labetalol 20 mg given intravenously foliwed by 10 mg increments to a total
dose of 1 mg/kg resulted, in reduction in mean artery blood pressure and heart rate and the
cardiovascular response to laiyngoscopy and intubation were reduced.
Nitroglycerine 0.1 micrograms/kg/min was not effective in preventing the hypertensive responses to
laryngoscopy while Esomolol could prevent the hypertensive response but has caused fetal hypoxemia
in animal studies43. Fentanyl I micrograms/kg or Alfantanil 10 micrograms/kg given at induction
attenuated these responses but did not abolish them completely44.
V. Pre-anaesthetic management/monitoring
Before any procedure is undertaken, it is mandatory to optimize the condition of the patient. We should
try to control the blood pressure, restore blood volume, improve renal function, institute anticonvulsant
therapy (if indicated) and initiate proper monitoring. The minimal monitoring employed should be
blood pressure by a non-invasive method, heart rate and urine output measurements. Direct intra-
arterial blood pressure monitoring is indicated in patients with severe pre-eclampsia or eclampsia.
Central venous pressure monitoring is indicated in severe pre- eclamptic and eclamptic patients as a
minimal invasive monitoring. They have clearly reduced blood volume and are fluid deficient. Volume
loading is often necessary, which could cause pulmonary oedema. Some anaesthesiologists
recommended the use of pulmonary arter catheter (P.A.C) for effective management of patients.
Informations gathered from P.A.C. can be used to institute therapy such as fluid challenges, potent
vasodilator infusion and beta adzcnergic blockade to optimize the patients haemodynamic status45.
P.A.C. is also indicated in pre- eclarnptic/eclampsia patients with unresponsive oliguria, pulmonary
oedema and in those cases where epidural anaesthesia is contemplated. However, some workers do not
think that pulmonary catheterization is strongly indicated and useful46. Electronic monitoring of fetal
heart rate and uterine contractions is essential, when labour is artificially induced or epidural analgesia
is instituted. Fetal blood analysis for PH may be indicated when significant fetal heart rate
abnormalities occur.
VI. Choice of Analgesia
Choice of analgesia will depend on obstetrical situation, the status of the patient and the condition of
the fetus (if still in utero). Narcotics provide good analgesia but have no anticonvulsant and
antihypertensive properties. Tranquilizers in combination with narcotics are in use and have variable
success with significant side effects. Patient controlled analgesia (PCA) with Fentanyl (loading dose of
50-100 micrograms followed by 25-50 micrograms hourly) or Meperidine (25-50 mg followed by 10-
15 mg/hour) may be used. A mixture of N20 and ox-ygen(50:50%) provides good analgesia and
increases oxygenation. This combination is effective during the late first stage and at delivery time.
Addition of 0.5-0.75% Enflurane or 0.3-0.5% Isoflurane or 0.5% Halothane to N20 plus 02 admixture
could produce the effective desired results for delivery. Local infiltration of perineum or Pudendal
nerve block provides satisfactory analgesia for most forceps deliveries.
Epidural analgesia
The use of continuous lumbar epidural analgesia in severe pre- eclamptics/eclamptics whose
convulsions are under control is widely accepted and recommended45,47-49 unless contraindicated due
to gross coagulation abnormalities, or marked untreated hype- volumia, or maternal septicemia.
Properly conducted epidural analgesia for labourand delivery, decreases maternal oxygen requirenients,
prevents maternal hyperventilation, significantly decreases circulating levels of Epinephrine50:
increases intervillous blood flow51; appears to protect against eclamptic convulsions52; chances of
pulmonary aspiration are minimized and stabilizes the blood pressure at modestly lower levels. All
these effects cause an improvement in mother’s clinical status; moral attitude and fetal well being.
Apgar score in neonates born to mothers with Epidural was far better than non-epidural group.
Concerns expressed by others are that epidural analgesia should not be used in severe pre-eclamptic
patients53. Sudden hypotension which could be deleterious to already compromised fetus due to further
decreases in uteroplacental blood flow54. Also anaesthetics used could decrease fetal beat-to-beat
variability and impede the diagnosis of fetal hypoxia and distress55. Due to cOagulopathy, in pre-
cclamptic patients formation of epidural haematoma is a possibility during invasive regional
techniques.
Studies have shown that. properly conducted epidural analgesia/anaesthesia does not cause significant
hypotension or fetal distress56. The decrease in blood pressure is comparable with non pre-eclamptic
normal patients57,58. A sequential technique, of raising the block in stages. rather than in a bolus is the
generally favoured approach. Ephedrine is the drug of choice for hypotension59. Animal and human
studies, including studies in pre-eclamptic parturients showed that intervillous blood flow was
maintained or improved with the use of epidural analgesia61,60. Anecdotal reports of epidural or
subarachnoid block inadvently administered to patients with platelets counts <100,000 mm3 have not
described any epidural haernatorna as a consequence61. Epidural block administered before delivery in
pre-eclamptic patients have not resulted in epidural haematoma even if the platelet numbers have
decreased below 50,000 mm3 after delivery. It is advisable to leave the catheter in place till the
coagulation profile including platelets are within normal acceptable limits.
The use of adrenaline in epidural space is controversial. Administration of adrenaline mixed local
anaesthetic could cause severe hypertensive response in patients with preeclampsia/eclampsia, due to
increased sensitivity to catecho lamine. However, others62 think adrenaline is safe as only B-adrenergic
effects are seen. Lidocaine does cause a slight decrease in fetal heart beat to beat variability, while
Bupivacinc use is not associated with decrease in fetal beat to beat variability63. Ideally, in patients
with severe pre- eclampsia institution of epidural analgesia should be proceeded by placing a CVP or
Pulmonary Artery Catheter64. Such patients should receive a balance salt solution and/orcolloid until
CVP is +3/+4 ems of water or pulmonary capillary wedge pressure is 5- 12 mmHg65.
In view of the vast favourable clinical experience and recent investigational work, the evidence
supports the use of epidural analgesia for labor, vaginal delivery and Cesarean section in most mothers
with severe pre-eclampsia or controlled eclarnpsia59.
General anaesthesia
While planning for general anaesthesia, the hazards and possible pmblems which could be encountered
in severe pre-cclamptic patients should be kept in mind. The major hazards are difficulties in airway
maintenance, excessive and aggregated response to laiyngoscopy and endotracheal intubation.
interaction of anaesthetic drugs with drugs used by obstetrician particularly magnesium sulphate.
Despite various hazards, some authorities feel that risks of rneral anaesthesia are less than those of
regional anaesthesia66 while others feel that general anaesthesia has markedly increased risks67.
Operation of the patient for general anaesthesia
a) P re-induction period
The earlier involvement of the anaesthesiologist is very important. The clinical condition of the patient
should be optimized before surgery. Blood pressure and convulsions should be properly controlled. All
antihypertensive and anticonvulsant drugs to be continued till patient is in the operating room. It is
advisable to bring patient to the operating room in the lateral position and have oxygen via face mask
during transportation. The usual doses of antiemetics (Metocloprarnide 10 rug IM) and antacids
(Sodium Citrate 0.30 mmol, 30 ml) or a H2 histamine receptor antagonist (Ranitidinc or Cimetidine or
Famotidine) be given orally 1-2 hours prior or 40-60 minutes earlier intravenously.
b) Induction period
In case of severe fetal distress or compromise, intravenous induction with agents such as Thiopentone
sodium or Propofol is likely to reduce placental perfusion with further detrimental effects to the fetus.
Ketamine is contraindicated while Etomidate has been condemned for undesirable effects on
adrenocortical axis, but is a relatively cardio stable drug. There may be ajustification for the use
ofbenzodiazepines for induction especially, when a specific benzodiazepine receptor antagonist
(Flumazenil) is available. The exaggerated pressor responses to laryngoscopy and intubation could be
attenuated by various techniques using drugs such a Hydralazine, Labetalol or Sodium Nitroprusside. A
rapid sequence technique should be used to secure the airway.
Intra-operative l)CflOd
Institution of LPPV can adversely affect the uterine blood flow by reducing cardiac output especially in
dehydrated or volume depleted patients. These patients should be kept normocapnic or somewhat
hypcrcapnic to improved placental blood flow and decrease shunting. Hyperventilation should be
avoided as it will lead to deterioration in uterine/placental blood flow due to decrease in cardiac out-
put, vasoconstnction and respiratory alkalosis which will shift the oxygen dissociation curve to the left.
It is well known that Nitrous Oxide has low lipid solubility and it has relatively rapid transplacental
passage which can cause some degree of neonatal depression during C-section. There is probably a
slight but definite real risk that the already hypoxic infant may be adversely affected by this agent.
However, if an unacceptable risk of maternal awareness at operation is to be avoided due to low
nitrous-oxide concentration or no nitrous oxide imposed by a high FIo2, additional vapor (inhalational)
supplementation will be required. In general the available evidence suggest that Halothane in a
concentration of 1.0 MAC or less has little or no effect on placental perfusion or fetal well-being, while
higher concentration result in deterioration68.
Various studies50,69 failed to show any adverse effects due to Halothane or Enflurane on the fetus as
determined by neonatal apgar score, acid-base status or earlier neuro-behavioral score when compared
with the other group which reccivedoxygen/nitrous oxide maintenance. Also 0.5%orless Halothane is
not associated with increased blood loss. Enflurane in low concentration is devoid of any adverse
effects on neonates when used as a supplementary agent in subanaesthetic concentrations during
labour50,69 Isoflurane has gained popularity due to properties of low blood solubility, apparent freedom
from hepatic and renal toxicity and relative cardiovascular stability. At equipotent concentrations it’s
effects on uterine contractility is similar to Halothane and Enflurane70, while maintaining normal
maternal and neonatal conditions. In another study, Isoflurane 0.75%was found to be preferable to
0.5% halothane during cesarean section because of more rapid recovery, less bleeding and less uterine
relaxation. Intra-operative muscle relaxation could be maintained by Suxamethonium infusion (4
mg/min or small boluses of a depolarizing agent in incremental doses, e.g., Vecuronium (1-2 mg) or
Atracrium (10-15 mg) adjusted as necessary using a nerve stimulator.
Extubation
The cardiovascular changes due to extubation could be as severe as pressor responses to intubation. At
this moment, neither narcotics due to their respiratory depressant effects nor Magnesium Sulphate due
to its neuromuscular blocking properties are likely to be ideal. The idea of extubating these patients in
the deeper planes should be addressed very carefully due to high potential for airway management
difficulties and aspiration. There is sonic role for vasodilators or beta-blockers especially short acting
such as Esmalol at this stage.
Post-operative care
The delivery of the fetus and placenta is the treatment but the full recovery may take 10 days to 2
weeks. The airway management may be more difficult in the postoperative period due to the worsened
laryngeal oedema situation. Respiratory embarrassment may be severe and airway maintenance may be
impossible without anendotrachealtube. The antihypertensive and anticonvulsant drugs should be
continued in the postoperative period as long as indicated. It is very important to keep these patients
pain free with good analgesia. Epidural analgesia is an ideal choice, if epidural catheter is in place.
These patients should be closely and maximally nionitored (both invasively and non-invasively) in the
Intensive Care Unit at least for the first 24 hours.
Key points for anaesthetic considerations
1) Essential monitoring:
a. Non-invasive monitoring. e.g.. ECG. pulse rate, blood pressure, pulse oximetrv. urine output.
b. Invasive monitoring, e.g., CVP. Swan Ganz Catheter, intraarterial blood pressure.
2) Prevention and control of convulsions by use of Magncsium Sulphate, Diazepam and Phenytoin.
3) Optimal stabilization of cardiovascular system by careful fluid balance and use of vasodilators.
4) Proper pre-anaesthetic evaluation of various systems with specific attention towards cardiovascular,
renal coagulation and hepatic system.
5) Anaesthetic choices:
a. Regional anaesthesia
A carefully administered epidural blockade is strongly advised, unless gross contraindications exists.
Epidural is absolutely contraindicated when platelets are less than 50,000/mm3. while between 50.000-
100,000/mm3, the risk balance should be assessed as possibility of haematoma incidence is 1:10,000
cases.
Subarachnoid block is not widely recommended due to the risk of sudden and severe hypotension.
b. General anaesthesia
It requires skilled ainvay management. control of pressor response to laryngoscopv and intubation,
awareness of the potential drugs interactions and careful postoperative management.
6) Avoidance of certain drugs i.e.. Methoxyflurane, Ketamine and Methergin: reduction in dosage of
Vasopressors when needed; prophylactic use of Ephedrine is not recommended and titration of muscle
relaxant drugs.
7) Proper management in the I.C.U. in the postoperative period. Anticonvulsant and antihypertensive
drugs to be continued as indicated. Good analgesia could be provided via the epidural route.
8) The successful management of these patients depends upon the team work and communications of
obstetrician, mid-wife and anaesthcsiologisL all of whom have iniportant roles to play. While (lie
majority of patients require minimal intervention, severe pre-ectamptic patients need expert care with
excess to invasive monitoring and therapy in the intensive care units.
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